During this initial phase, its important to monitor for any adverse reactions and assess individual tolerance
raises IGF-1 and carries glucose-tolerance risk Compound Semaglutide (Wegovy) Class GLP-1 receptor agonist FDA Status FDA-approved for chronic weight management Evidence Strength Phase 3 RCTs
In the apitherapeutic treatment, BP is used because it shows medicinal activities such as antimicrobial, antibiotic, anti-inflammatory, antiviral, analgesic, immunostimulant (8486), anti-radiation, anti-tyrosinase, hepatoprotective, and antioxidant (22, 8789) (Figures 1, 2)
1997 May-Oct;91(3-5):139-49